DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 168 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $153,000 | -33.8% | 10,848 | -79.1% | 0.00% | – |
| Q4 2020 | $231,000 | +23.5% | 51,848 | +19.7% | 0.00% | – |
| Q3 2020 | $187,000 | -64.7% | 43,308 | -27.5% | 0.00% | -100.0% |
| Q2 2020 | $530,000 | +430.0% | 59,708 | +137.2% | 0.00% | – |
| Q2 2019 | $100,000 | -56.9% | 25,177 | -20.8% | 0.00% | – |
| Q1 2019 | $232,000 | -12.1% | 31,803 | +10.1% | 0.00% | – |
| Q4 2018 | $264,000 | -36.5% | 28,882 | -13.9% | 0.00% | -100.0% |
| Q3 2018 | $416,000 | -20.8% | 33,562 | -2.5% | 0.00% | 0.0% |
| Q2 2018 | $525,000 | +109.2% | 34,435 | +195.0% | 0.00% | 0.0% |
| Q3 2017 | $251,000 | +512.2% | 11,673 | +11.4% | 0.00% | – |
| Q4 2016 | $41,000 | -63.7% | 10,482 | -3.1% | 0.00% | – |
| Q3 2016 | $113,000 | -81.1% | 10,812 | -55.7% | 0.00% | -100.0% |
| Q3 2015 | $598,000 | +8.9% | 24,380 | +4.0% | 0.00% | 0.0% |
| Q2 2015 | $549,000 | -1.4% | 23,437 | -5.6% | 0.00% | 0.0% |
| Q1 2015 | $557,000 | – | 24,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |